Search results
-
Sustainability without compromise ChromaPur
Small, manufactured plastic particles, known as microbeads, are used in a wide range of cosmetic and personal care products, with research suggesting that 87% of products from the ten best-selling cosmetics brands contain these microplastics.
-
Leveraging Group-wide capabilities to accelerate the development of natural active ingredients
The move in cosmetics towards replacing synthetic ingredients with sustainable alternatives is increasing demand for naturally sourced actives.
-
Biodegradable fragrance encapsulation
Fragrance encapsulation involves advanced delivery systems that allow the timed release of fragrances, critical in various applications such as laundry, fabric softeners and deodorants.
-
Croda supports Pfizer-BioNTech COVID-19 vaccine
Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs.
-
Investing in organic expansion in Agriculture
Atlox 4913TM is valued by customers for creating stable dispersions in complex crop formulations, ensuring consistent distribution of actives and preventing formulation breakdown.
-
Symiro™ biostimulant
As the challenge to feed our growing global population continues, increasing crop growth and yields is becoming an important area of focus to meet the rising demand for food.
-
Mexico
In 1977, a joint venture company was formed in Mexico, Quimica Croda SA.
-
About us
We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.
-
Our centenary
2025 is Croda’s centenary year which provides an excellent opportunity to celebrate our rich history and reflect on the strong foundations it gives us for future success.
-
Careers
Here at Croda, our people and operations are what make us who we are, we have people across the world, operating in 37 different countries.
-
Share price
Detailed share charts.
-
Singapore
Croda Singapore was founded in 1986 and is the regional headquarters of the Asia Pacific region.
-
Shareholder information
Keep up to date with shareholder and investor information.
-
Croda launches animated timeline to showcase 100 years of innovation
13 February 2025: Croda today launches an animated historical timeline to mark its centenary year.
-
Finance review 2025
“With a comprehensive transformation programme that is driving both growth and efficiencies, we are firmly focused on execution. Progress so far has been encouraging, and we are setting out a financial framework to full year 2028 that outlines further improvements in financial performance.”
-
Supporting Invisible Disabilities Week at Croda
Learn how Croda supports Invisible Disabilities Week, promoting awareness and inclusivity for employees with hidden disabilities. Discover personal stories, like Sana Bell’s, and our commitment to creating a supportive workplace for everyone to thrive.
-
Customer driven
We are listening more closely to our customers than ever before; understanding the things that are of most importance to our customers and how we are performing against them.
-
Advancing the efficacy and impact of vaccines
The acquisition of Biosector in 2018 strengthened our pharmaceutical offering, taking us into the field of vaccine adjuvants.
-
Acts of kindness
The Croda Acts of Kindness programme gave employees the opportunity to nominate local causes and charities to support during COVID-19, with each major site given £10,000.
-
Abiotic stress mitigation in onions
Changing climates mean higher temperatures, periods of drought and higher salinity are becoming an increasing problem for farmers.
-
Flue2Chem
In another example of industry-wide collaboration to help tackle the climate emergency, the Flue2Chem Innovate UK project aims to demonstrate that a UK supply chain to produce alkoxylated surfacants from CO2 is economically and technically feasible.
-
Digitalisation in manufacturing
We can see the potential of big data, robotics, analytics and the Internet of Things to drive manufacturing excellence and contribute to our right first time agenda.
-
Net zero roadmap for UK manufacturing site
We became one of the first UK manufacturing sites to develop a 2050 net zero roadmap as part of the UK Government’s Department for Business, Energy and Industrial Strategy ‘Industry of the Future’ programme.
-
Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture
Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.
-
Advocating for Access and Benefit Sharing and biodiversity conservation
We supported the launch of the third edition of the Brogota Project through the United Nations Biodiversity Conference COP15 side event.
-
Improving performance by humanising safety
Involvement and engagement have increased, and longstanding infrastructure and operational issues are being addressed following a pilot Human Performance Programme at our site in Thane, India.
-
Transition to bio-based MPG
Transitioning our raw materials to bio-based sources will enable us to make a significant positive impact.
-
Life cycle assesment
Supporting our customers to realise the benefits of LCA meant that in 2022 we began developing our LCA Centre of Excellence, supporting sectors in examining the risks and benefits of their portfolios.
-
Industrial Specialties business review
Discover how Industrial Specialties is enabling continued growth, exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.
-
Uni of Cambridge case study
Working with technology designers NiTech Solutions and The University of Cambridge’s Institute for Manufacturing, we created a new process to manufacture more sustainable surfactants. Traditionally, industrial production of surfactants often occurs in large batch reactors, which have low energy efficiency and a long reaction time.
-
Leveraging expertise in UV filters for Asian markets
There are over three million cases of skin cancer globally each year, responsible for tens of thousands of deaths. Our range of sunscreens meets a clear need and is an important pillar of our sustainability Commitment to be People Positive by 2030.
-
Human Performance programme
Our behavioural safety improvement programmes were standardised into a Group-wide Behavioural Safety Observation programme, implemented across all manufacturing sites since 2015.
-
Reforestation
Revitalising ecosystems, improving biodiversity and creating social and economic benefits for local communities.
-
1.5°C science-based target validation
In July 2021 we became only the third major chemical company globally to have a 1.5ºC science-based target validated.
-
Croda Foundation
We have taken a big step towards achieving our ambition of expanding the reach of our smart science to permanently improve more lives by funding the Croda Foundation.
-
Collaboration to deliver new vaccine adjuvants
In 2021 we established a strategic collaboration with the Danish government’s life science research institute, Statens Serum Institute (SSI).
-
Responsible business
/Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image
-
Coltide Radiance sustainability in use
In October we were delighted that our sustainability leadership was recognised as we won Business of the Year at the World Sustainability Awards.
-
Waste management
Iberchem, our global fragrance and flavours business based in Spain, has championed waste management best practices through robust policies and employee education programmes.
-
Agroforestry in the Amazon
The Croda Foundation is supporting an Instituto Amazonas agroforestry project, which aims to revive traditional agriculture practices among indigenous tribes, improving food security and protecting their cultural heritage and environment.
-
Consumer Care sustainability review
Connecting sustainability to people, making it personal, is core to the sustainability focus within the Consumer Care business. Consumers desire personal care products that deliver performance, without negatively impacting the planet. Keeping this at the core creates value for our customers’ brands and the consumers they serve.
-
Improving the customer experience in China
Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.
-
Supplying delivery systems to help prevent cardiovascular disease
Nucleic acid-based therapies are the next big blockbuster drug class opening up exciting applications such as gene editing, where a patient’s genetic material can be modified to correct a disorder.
-
Supporting the next generation of therapeutic vaccines
Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.
-
Navigating the future of innovative ingredients
As Croda celebrates 100 years of delivering Smart science to improve lives™, we’re also looking ahead. This Vision Report is a forward-looking guide to the trends that will reshape the speciality ingredients industry across the next quarter-century.
-
Bringing anti-ageing benefits to make-up
Developed through one of our Smart Partnerships, Majestem® Drypure™ from our beauty actives business, Sederma, brings anti-ageing and environmental protection benefits to make-up.
-
Sustainability-linked revolving credit facility
In 2019, we became one of the UK’s first large public companies to include a sustainability metric in a revolving credit facility (RCF), with targets in the seven-year agreement aligned with our 2030 Commitment to become Climate Positive.
-
100 years of smart science: Celebrating Croda's centenary across the globe
Join us as we celebrate Croda’s 100-year journey from a small family firm in Yorkshire to a global leader in sustainable innovation. Discover the science, stories, and people behind a century of improving lives.
-
Collaboration to develop alternative vaccine adjuvants
In 2021 we established a strategic collaboration with the Danish Government’s life science research institute, Statens Serum Institute (SSI).
-
Sustainability Progress Statement
Explore our 2025 Sustainability Progress Statement to see how we’re driving measurable progress on climate action, responsible sourcing, and social impact, creating sustainable solutions that deliver lasting value for our customers, communities, and the planet.